the Web site devoted to the study of the glucagon-like peptides

This Web site is maintained by Dr. Daniel J. Drucker, Mount Sinai Hospital Samuel Lunenfeld Research Institute University of Toronto

Exenatide efficacy in human subjects with Parkinson's disease GLP-1 action in the CNS

Updated pooled analysis of sitagliptin safety from 25 clinical trials GLP-1 Adverse Events

Overview of incretin biology


WWW glucagon.com

For updates to glucagon.com, Follow us on Twitter DanielJDrucker